INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2015

Maca root (3.0 g/day) resulted in higher remission rates of antidepressant-induced sexual dysfunction than placebo, particularly in postmenopausal women.

A 12-week double-blind, placebo-controlled trial evaluated maca root (3.0 g/day) in 45 female outpatients with remitted depression and SSRI/SNRI-induced sexual dysfunction, with 42 eligible for modified intent-to-treat analysis. Remission rates at the end of treatment were higher with maca than placebo for an ASEX score ≤ 10 (9.5% vs. 4.8%), an MGH-SFQ score ≤ 12 (30.0% vs. 20.0%), and an MGH-SFQ score ≤ 8 (9.5% vs. 5.0%). Higher remission rates with maca compared to placebo were associated with postmenopausal status. Maca was reported to be well tolerated.

Study type
12-week double-blind placebo-controlled randomized trial
Who was studied
45 female outpatients (mean age 41.5 ± 12.5 years) with remitted depression and SSRI/SNRI-induced sexual dysfunction (42 analyzed)
What was measured
Improvement in sexual functioning assessed by ASEX and MGH-SFQ

THE PAPER

A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women.

Dording CM, Schettler PJ, Dalton ED, Parkin SR, Walker RS, Fehling KB, Fava M, Mischoulon D. Evid Based Complement Alternat Med, 2015.

PubMed 25954318 ↗DOI 10.1016/j.maturitas.2010.04.019 ↗

Brain & moodOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.